Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9005499 | Clinical Therapeutics | 2005 | 7 Pages |
Abstract
Both IFN and gemfibrozil inhibitthe activity of the hepatic enzymes CYP1A2 and CYP2C19. A possible drug-drug interaction between IFN alfa 11 MU TIW and gemfibrozil 600 mg BID was reported in a patient undergoing treatment for IFN-induced hypertriglyceridemia.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
PharmD Wong, MD2 Jakowatz, PharmD Taheri,